The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
Key takeaways of recent quarter & conference call highlights
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Ind-Ra expects revenue growth of over 12% in 2022.
EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
Flattish volume growth and subdued new launches were key factors for last month
Subscribe To Our Newsletter & Stay Updated
